EPTIS
BAM Logo

Virus Genome Detection – Coronaviruses

[Virusgenom-Nachweis – Coronaviren]

EPTIS factsheet 437169 | Last revision 2020-04-15 | URL: https://www.eptis.bam.de/pts437169 https://www.eptis.bam.de/pts437169

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks Option of differentiation between MERS coronavirus and other human coronaviruses (samples which contain the MERS coronavirus are inactivated), MERS coronavirus (RNA) - quantitative, MERS coronavirus (RNA) - qualitative, other human coronaviruses (RNA) - quantitative, other human coronaviruses (RNA) - qualitative, SARS-CoV-2 (RNA) - quantitative, SARS-CoV-2 (RNA) - qualitative Next Terms: June 2020: Registration Deadline: April 17th 2020 November 2020: Registration Deadline: September 25th 2020 Please fill in page 2 of the order form for handling of infectious samples for EQAS unless you already returned your completed form 2 to INSTAND e. V. when you registered for recent EQA schemes. Without your confirmation we cannot send you the EQAS samples. The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. EQA results can only be submitted online! Cooperation with: Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité-Universitätsmedizin Berlin
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised cell culture lysates PCR and other nucleic acid amplification techniques (NAT) for CoV RNA with the option for differentiation between SARS-CoV-2, MERS coronavirus and other human coronaviruses (samples which contain the SARS-CoV-2 and/or MERS coronavirus are inactivated) -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants >200
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee 295 € / Survey
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430
Fax:
Email: weiss@instand-ev.de weiss@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5